21-46416679-G-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006031.6(PCNT):c.6761G>T(p.Cys2254Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000511 in 1,565,204 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C2254Y) has been classified as Likely benign.
Frequency
Consequence
NM_006031.6 missense
Scores
Clinical Significance
Conservation
Publications
- microcephalic osteodysplastic primordial dwarfism type IIInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
- Moyamoya diseaseInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006031.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PCNT | NM_006031.6 | MANE Select | c.6761G>T | p.Cys2254Phe | missense | Exon 30 of 47 | NP_006022.3 | ||
| PCNT | NM_001315529.2 | c.6407G>T | p.Cys2136Phe | missense | Exon 30 of 47 | NP_001302458.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PCNT | ENST00000359568.10 | TSL:1 MANE Select | c.6761G>T | p.Cys2254Phe | missense | Exon 30 of 47 | ENSP00000352572.5 | ||
| PCNT | ENST00000480896.5 | TSL:1 | c.6407G>T | p.Cys2136Phe | missense | Exon 30 of 47 | ENSP00000511989.1 | ||
| PCNT | ENST00000695558.1 | c.6794G>T | p.Cys2265Phe | missense | Exon 31 of 48 | ENSP00000512015.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152174Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00 AC: 0AN: 207318 AF XY: 0.00
GnomAD4 exome AF: 0.00000495 AC: 7AN: 1413030Hom.: 0 Cov.: 34 AF XY: 0.00000717 AC XY: 5AN XY: 697394 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74340 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.6761G>T (p.C2254F) alteration is located in exon 30 (coding exon 30) of the PCNT gene. This alteration results from a G to T substitution at nucleotide position 6761, causing the cysteine (C) at amino acid position 2254 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
PCNT-related disorder Uncertain:1
The PCNT c.6761G>T variant is predicted to result in the amino acid substitution p.Cys2254Phe. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at